534.4000 0.90 (0.17%)
NSE Jun 18, 2026 15:31 PM
Volume: 475.4K
 

Angel Broking
Thyrocare Technologies is one of the leading diagnostic chains in India with market share of ~3% amongst organised players. The core business of the company is diagnostic testing (~97.1% of sales as on 9MFY2016) while the company through its wholly owned subsidiary also operates imaging centres. A differentiated model enables higher margi..
Number of FII/FPI investors increased from 128 to 137 in Mar 2026 qtr.
More from Thyrocare Technologies Ltd.
Recommended